Literature DB >> 16439538

Functional analysis of hepatitis C virus envelope proteins, using a cell-cell fusion assay.

Mariko Kobayashi1, Michael C Bennett, Theodore Bercot, Ila R Singh.   

Abstract

Hepatitis C virus (HCV) envelope proteins mediate the entry of virus into cells by binding to cellular receptors, resulting in fusion of the viral membrane with the host cell membrane and permitting the viral genome to enter the cytoplasm. We report the development of a robust and reproducible cell-cell fusion assay using envelope proteins from commonly occurring genotypes of HCV. The assay scored HCV envelope protein-mediated fusion by the production of fluorescent green syncytia and allowed us to elucidate many aspects of HCV fusion, including the pH of fusion, cell types that permit viral entry, and the conformation of envelope proteins essential for fusion. We found that fusion could be specifically inhibited by anti-HCV antibodies and by at least one peptide. We also generated a number of insertional mutations in the envelope proteins and tested nine of these using the fusion assay. We demonstrate that this fusion assay is a powerful tool for understanding the mechanism of HCV-mediated fusion, elucidating mutant function, and testing antiviral agents.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16439538      PMCID: PMC1367170          DOI: 10.1128/JVI.80.4.1817-1825.2006

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

Review 1.  Folding, assembly and subcellular localization of hepatitis C virus glycoproteins.

Authors:  J Dubuisson
Journal:  Curr Top Microbiol Immunol       Date:  2000       Impact factor: 4.291

2.  Comprehensive mutational analysis of a herpesvirus gene in the viral genome context reveals a region essential for virus replication.

Authors:  Anja Bubeck; Markus Wagner; Zsolt Ruzsics; Mark Lötzerich; Margot Iglesias; Ila R Singh; Ulrich H Koszinowski
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 3.  Acidification of the endocytic and exocytic pathways.

Authors:  I Mellman; R Fuchs; A Helenius
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

4.  Regulated expression of foreign genes in vaccinia virus under the control of bacteriophage T7 RNA polymerase and the Escherichia coli lac repressor.

Authors:  W A Alexander; B Moss; T R Fuerst
Journal:  J Virol       Date:  1992-05       Impact factor: 5.103

Review 5.  Functional hepatitis C virus envelope glycoproteins.

Authors:  Cécile Voisset; Jean Dubuisson
Journal:  Biol Cell       Date:  2004-08       Impact factor: 4.458

6.  Characterization of infectious retroviral pseudotype particles bearing hepatitis C virus glycoproteins.

Authors:  Mike Flint; Carine Logvinoff; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

7.  CD81 is required for hepatitis C virus glycoprotein-mediated viral infection.

Authors:  Jie Zhang; Glenn Randall; Adrian Higginbottom; Peter Monk; Charles M Rice; Jane A McKeating
Journal:  J Virol       Date:  2004-02       Impact factor: 5.103

Review 8.  Peptide inhibitors of virus-cell fusion: enfuvirtide as a case study in clinical discovery and development.

Authors:  David A Cooper; Joep M A Lange
Journal:  Lancet Infect Dis       Date:  2004-07       Impact factor: 25.071

9.  Expression of unmodified hepatitis C virus envelope glycoprotein-coding sequences leads to cryptic intron excision and cell surface expression of E1/E2 heterodimers comprising full-length and partially deleted E1.

Authors:  Julie Dumonceaux; Emmanuel G Cormier; Francis Kajumo; Gerald P Donovan; Jayanta Roy-Chowdhury; Ira J Fox; Jason P Gardner; Tatjana Dragic
Journal:  J Virol       Date:  2003-12       Impact factor: 5.103

10.  Cell surface expression of fusogenic vesicular stomatitis virus G protein from cloned cDNA.

Authors:  H Riedel; C Kondor-Koch; H Garoff
Journal:  EMBO J       Date:  1984-07       Impact factor: 11.598

View more
  13 in total

Review 1.  Studying hepatitis C virus: making the best of a bad virus.

Authors:  Timothy L Tellinghuisen; Matthew J Evans; Thomas von Hahn; Shihyun You; Charles M Rice
Journal:  J Virol       Date:  2007-05-23       Impact factor: 5.103

2.  Transmembrane domains of hepatitis C virus envelope glycoproteins: residues involved in E1E2 heterodimerization and involvement of these domains in virus entry.

Authors:  Yann Ciczora; Nathalie Callens; François Penin; Eve-Isabelle Pécheur; Jean Dubuisson
Journal:  J Virol       Date:  2006-12-13       Impact factor: 5.103

3.  Biochemical mechanism of hepatitis C virus inhibition by the broad-spectrum antiviral arbidol.

Authors:  Eve-Isabelle Pécheur; Dimitri Lavillette; Fanny Alcaras; Jennifer Molle; Yury S Boriskin; Michael Roberts; François-Loïc Cosset; Stephen J Polyak
Journal:  Biochemistry       Date:  2007-04-25       Impact factor: 3.162

4.  Characterization of fusion determinants points to the involvement of three discrete regions of both E1 and E2 glycoproteins in the membrane fusion process of hepatitis C virus.

Authors:  Dimitri Lavillette; Eve-Isabelle Pécheur; Peggy Donot; Judith Fresquet; Jennifer Molle; Romuald Corbau; Marlène Dreux; François Penin; François-Loïc Cosset
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

Review 5.  Roles of lipoprotein receptors in the entry of hepatitis C virus.

Authors:  Jingya Lyu; Hitomi Imachi; Kensaku Fukunaga; Takuo Yoshimoto; Huanxiang Zhang; Koji Murao
Journal:  World J Hepatol       Date:  2015-10-28

6.  Low pH-dependent hepatitis C virus membrane fusion depends on E2 integrity, target lipid composition, and density of virus particles.

Authors:  Sibylle Haid; Thomas Pietschmann; Eve-Isabelle Pécheur
Journal:  J Biol Chem       Date:  2009-05-01       Impact factor: 5.157

7.  Identification of conserved residues in the E2 envelope glycoprotein of the hepatitis C virus that are critical for CD81 binding.

Authors:  Ania M Owsianka; Judith M Timms; Alexander W Tarr; Richard J P Brown; Timothy P Hickling; Aleksandra Szwejk; Krystyna Bienkowska-Szewczyk; Brian J Thomson; Arvind H Patel; Jonathan K Ball
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

8.  Mechanism of inhibition of enveloped virus membrane fusion by the antiviral drug arbidol.

Authors:  Elodie Teissier; Giorgia Zandomeneghi; Antoine Loquet; Dimitri Lavillette; Jean-Pierre Lavergne; Roland Montserret; François-Loïc Cosset; Anja Böckmann; Beat H Meier; François Penin; Eve-Isabelle Pécheur
Journal:  PLoS One       Date:  2011-01-25       Impact factor: 3.240

9.  Arbidol: a broad-spectrum antiviral that inhibits acute and chronic HCV infection.

Authors:  Yury S Boriskin; Eve-Isabelle Pécheur; Stephen J Polyak
Journal:  Virol J       Date:  2006-07-19       Impact factor: 4.099

10.  Enhancement of the influenza A hemagglutinin (HA)-mediated cell-cell fusion and virus entry by the viral neuraminidase (NA).

Authors:  Bin Su; Sébastien Wurtzer; Marie-Anne Rameix-Welti; Dominic Dwyer; Sylvie van der Werf; Nadia Naffakh; François Clavel; Béatrice Labrosse
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.